NEWS

NEWS TYPE
RELEASE YEAR

EVENT

【7/24Seminar】The 3rd/4th Structural Biology Colloquium: Atsushi Yamagata, PhD & Reiya Taniguchi, PhD

July 22, 2026

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows.
This is an event for faculty, students, and staff of Keio University.

Understanding biology by cryoEM analysis -AI-based design, toxin, in-situ structure etc –

Date & Time: 15:00 -17:00, July 24, 2026

Venue: 3F Meeting room, Center for Integrated Medical Research, Shinanomachi Campus, Keio University

Onsite only / No pre-registration required

Speaker 1:
Atsushi Yamagata, PhD
Senior Scientist, Laboratory for Protein Function and Structural Biology RIKEN Center for Biosystems Dynamics Research , Yokohamal, Japan

Title:
“Structural Insights into the Synaptic Targeting Mechanisms of Botulinum Neurotoxin and Racetam-Based Antiepileptic Drugs”

Abstract:
Synaptic vesicle glycoprotein 2A (SV2A) is an abundant membrane protein in synaptic vesicles, although its physiological function remains poorly understood. It serves as a receptor for botulinum neurotoxins and as the molecular target of the antiepileptic drugs levetiracetam (LEV) and brivaracetam (BRV).
We determined the cryo-electron microscopy (cryo-EM) structures of SV2A in complex with the receptor-binding domain of botulinum neurotoxin A2 (BoNT/A2 Hc), as well as with LEV and BRV. Botulinum neurotoxin recognizes the luminal domain of SV2A through both protein–protein and protein–glycan interactions. LEV and BRV bind to the putative substrate-binding pocket in the outward-open conformation of SV2A. Using a newly developed label-free spectral shift assay, we further demonstrated that van der Waals interactions between the propyl group of BRV and SV2A are responsible for the higher binding affinity of BRV over LEV.
In this presentation, I will describe these structural studies and our recent efforts to elucidate the physiological functions of the SV2 family using proximity-dependent biotin identification (BioID). In addition, I will introduce our ongoing AI-driven binder design project targeting SV2A for the visualization of synaptic density.

Speaker 2:
Reiya Taniguchi, PhD
Team director, Laboratory for in situ Structural Biology RIKEN Center for Integrated Medical Sciences (IMS), Yokohama, Japan

Title:
“Visualizing the structural heterogeneity of the nuclear pore complex with cryo-ET”

Abstract:
Cryo-electron tomography (cryo-ET) is a technique for visualizing three-dimensional architecture of frozen biological specimens by computationally reconstructing volumes from a series of two-dimensional projection images acquired at multiple tilt angles. Combined with cryo-focused ion beam milling, cryo-ET has become a powerful tool for analyzing the structures of macromolecular complexes directly inside cells or tissues. Moreover, recent advances in image processing have enabled detailed analyses of the structural heterogeneity among particles in situ.
In this talk, I will present our in situ cryo-ET analysis of the nuclear pore complex (NPC) in mouse embryonic stem cells, which uncovered unexpected structural heterogeneity among NPC particles. Using fluorescence imaging as a complementary approach, we obtained insights into the functional significance of the NPC architecture in maintaining nuclear envelope integrity. This work highlights the strength of cryo-ET for analyzing the structural heterogeneity of macromolecular complexes in situ, and demonstrates its power for addressing fundamental questions in cell biology. I will also briefly discuss the current challenges and future perspectives of the field of in situ cryo-ET.

 

More Bio2Q News

ANNOUNCEMENT
2026.11.20

【Nov. 25 Seminar】 WPI-Bio2Q Open Seminar: Xu Zhang, PhD(for Keio Members)

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This event is only for faculty, students, and staff of Keio University.   Date and Time  Wednesday, November 25, 2026, 11:00-11:40 Format Zoom (Online only) Title Senescent Cell–Derived Factors Suppress Innate Antiviral Immunity During Aging Speaker Xu Zha...

EVENT
2026.11.17

【Event Report】Bio2Q Participates in the 15th WPI Science Symposium, Engaging wit...

On Saturday, November 14, 2026, the 15th WPI Science Symposium, themed “World Premieres Born from Me! ~Science I Want to Share with Someone~,” was held at the Osaka University Convention Center in Suita, Osaka, hosted by the Osaka University Premium Research Institute for Human Metaverse Medicine (WPI-PRIMe). The event featured a special lecture by Prof. Shimon Sakaguchi (Distinguished University ...

ANNOUNCEMENT
2026.11.16

WPI-Bio2Q now recruiting administrative staff– Deadline: January 11, 2027

WPI-Bio2Q Administrative Office is currently hiring administrative staff. We look forward to receiving applications from candidates with English proficiency who can support international researchers and anticipate to work at Bio2Q Administrative Office. Application Deadline: January 11, 2027 For more details, please refer to the application information at the link below, Application Info...

ANNOUNCEMENT
2026.11.12

New Long-Term Internship Student-Mr. Kevin Deesy

Introducing a new Long-Term Internship Student of Bio2Q We are delighted to welcome Mr. Kevin Deesy as a new Long-Term Research Internship Student of Bio2Q. "Hello Bio2Q team, My name is Kevin Deesy, and I’m currently completing my Master’s in Sustainable Food at the Technical University of Munich (TUM), specializing in molecular biotechnology and microbiology. My research so far has take...

ANNOUNCEMENT
2026.11.10

New Member - Dr. Augustinas Silale

Introducing new member of Bio2Q We are excited to welcome Dr.  Augustinas Silale as a Jr. PI at Bio-2 Core of Bio2Q. "Hello, Bio2Q community! My name is Augustinas (August) Silale. I am from Lithuania. I am delighted to join Bio2Q as a Jr. PI. I read Natural Sciences at the University of Cambridge. My BA project was on fragment-based drug discovery in Prof Sir Tom Blundell’s group, where ...